

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of mitochondrial fission (GO:0090141) | 4.22252010 |
| 2 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.77673920 |
| 3 | Golgi transport vesicle coating (GO:0048200) | 3.53335400 |
| 4 | COPI coating of Golgi vesicle (GO:0048205) | 3.53335400 |
| 5 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.31673037 |
| 6 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.29698875 |
| 7 | Golgi to endosome transport (GO:0006895) | 3.23696272 |
| 8 | activation of protein kinase A activity (GO:0034199) | 3.20768291 |
| 9 | locomotory exploration behavior (GO:0035641) | 3.08554624 |
| 10 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.01302262 |
| 11 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.96180831 |
| 12 | regulation of synaptic vesicle transport (GO:1902803) | 2.95691003 |
| 13 | alpha-linolenic acid metabolic process (GO:0036109) | 2.95093472 |
| 14 | regulation of mitochondrial fission (GO:0090140) | 2.93278708 |
| 15 | gamma-aminobutyric acid transport (GO:0015812) | 2.88810361 |
| 16 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.86800744 |
| 17 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.86592128 |
| 18 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.86463721 |
| 19 | synaptic vesicle exocytosis (GO:0016079) | 2.85147388 |
| 20 | exocrine pancreas development (GO:0031017) | 2.84476985 |
| 21 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.83119002 |
| 22 | piRNA metabolic process (GO:0034587) | 2.81931110 |
| 23 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.77718810 |
| 24 | response to lipoprotein particle (GO:0055094) | 2.76868367 |
| 25 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.75395986 |
| 26 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.74104159 |
| 27 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.73690150 |
| 28 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 2.72487724 |
| 29 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.72121769 |
| 30 | protein localization to synapse (GO:0035418) | 2.71534628 |
| 31 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.70120726 |
| 32 | biotin metabolic process (GO:0006768) | 2.69868911 |
| 33 | regulation of synapse structural plasticity (GO:0051823) | 2.66568138 |
| 34 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.65208072 |
| 35 | tricarboxylic acid cycle (GO:0006099) | 2.62948906 |
| 36 | neurotransmitter secretion (GO:0007269) | 2.61963258 |
| 37 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.61198701 |
| 38 | succinate metabolic process (GO:0006105) | 2.60978829 |
| 39 | positive regulation of glycolytic process (GO:0045821) | 2.60875290 |
| 40 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.60688620 |
| 41 | positive regulation of growth hormone secretion (GO:0060124) | 2.59990804 |
| 42 | regulation of protein glycosylation (GO:0060049) | 2.59671906 |
| 43 | response to pheromone (GO:0019236) | 2.59043934 |
| 44 | detection of calcium ion (GO:0005513) | 2.58633587 |
| 45 | exploration behavior (GO:0035640) | 2.58441692 |
| 46 | regulation of ARF protein signal transduction (GO:0032012) | 2.57376016 |
| 47 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.57153525 |
| 48 | regulation of pigment cell differentiation (GO:0050932) | 2.55626179 |
| 49 | lipid particle organization (GO:0034389) | 2.52618935 |
| 50 | cellular potassium ion homeostasis (GO:0030007) | 2.52055235 |
| 51 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.51947580 |
| 52 | potassium ion import (GO:0010107) | 2.51081100 |
| 53 | synaptic vesicle maturation (GO:0016188) | 2.50542726 |
| 54 | protein targeting to lysosome (GO:0006622) | 2.50517451 |
| 55 | establishment of protein localization to vacuole (GO:0072666) | 2.50517451 |
| 56 | protein targeting to vacuole (GO:0006623) | 2.50517451 |
| 57 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.49926615 |
| 58 | layer formation in cerebral cortex (GO:0021819) | 2.48282008 |
| 59 | nucleobase catabolic process (GO:0046113) | 2.47994044 |
| 60 | L-fucose catabolic process (GO:0042355) | 2.47482359 |
| 61 | fucose catabolic process (GO:0019317) | 2.47482359 |
| 62 | L-fucose metabolic process (GO:0042354) | 2.47482359 |
| 63 | righting reflex (GO:0060013) | 2.47253958 |
| 64 | COPII vesicle coating (GO:0048208) | 2.45424729 |
| 65 | axonal fasciculation (GO:0007413) | 2.45307631 |
| 66 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.44726262 |
| 67 | insulin secretion (GO:0030073) | 2.44053943 |
| 68 | glutamate secretion (GO:0014047) | 2.43460591 |
| 69 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.43283638 |
| 70 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.42981468 |
| 71 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.42579126 |
| 72 | microtubule anchoring (GO:0034453) | 2.42473454 |
| 73 | cell communication by electrical coupling (GO:0010644) | 2.42425178 |
| 74 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.41883865 |
| 75 | negative regulation of neurotransmitter transport (GO:0051589) | 2.41163435 |
| 76 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.40763877 |
| 77 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.40735326 |
| 78 | DNA methylation involved in gamete generation (GO:0043046) | 2.40695878 |
| 79 | cellular response to glucagon stimulus (GO:0071377) | 2.40092178 |
| 80 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 2.38607126 |
| 81 | positive regulation of fatty acid oxidation (GO:0046321) | 2.38381996 |
| 82 | peroxisome fission (GO:0016559) | 2.38331828 |
| 83 | lactate metabolic process (GO:0006089) | 2.37030242 |
| 84 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.36181354 |
| 85 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.35645230 |
| 86 | interkinetic nuclear migration (GO:0022027) | 2.33448490 |
| 87 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.32215175 |
| 88 | nerve growth factor signaling pathway (GO:0038180) | 2.30957380 |
| 89 | regulation of Rac protein signal transduction (GO:0035020) | 2.30820967 |
| 90 | positive regulation of protein autophosphorylation (GO:0031954) | 2.30349495 |
| 91 | establishment of nucleus localization (GO:0040023) | 2.29333027 |
| 92 | vocalization behavior (GO:0071625) | 2.29140556 |
| 93 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.28360579 |
| 94 | neuron recognition (GO:0008038) | 2.27699639 |
| 95 | proline transport (GO:0015824) | 2.27694018 |
| 96 | vesicle coating (GO:0006901) | 2.27455154 |
| 97 | catecholamine transport (GO:0051937) | 2.27110847 |
| 98 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.26981973 |
| 99 | regulation of RNA export from nucleus (GO:0046831) | 2.26793985 |
| 100 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.26154077 |
| 101 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.25626482 |
| 102 | sodium ion export (GO:0071436) | 2.25552212 |
| 103 | protein targeting to Golgi (GO:0000042) | 2.24378823 |
| 104 | dendrite morphogenesis (GO:0048813) | 2.23586670 |
| 105 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.22919707 |
| 106 | fucosylation (GO:0036065) | 2.22911689 |
| 107 | protein localization to Golgi apparatus (GO:0034067) | 2.22156427 |
| 108 | vesicle transport along microtubule (GO:0047496) | 2.22001171 |
| 109 | innervation (GO:0060384) | 2.21956752 |
| 110 | regulation of growth hormone secretion (GO:0060123) | 2.21631216 |
| 111 | auditory behavior (GO:0031223) | 2.20268307 |
| 112 | gene silencing by RNA (GO:0031047) | 2.20179201 |
| 113 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.19793845 |
| 114 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.19604010 |
| 115 | sympathetic nervous system development (GO:0048485) | 2.19399940 |
| 116 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.19051093 |
| 117 | endoplasmic reticulum organization (GO:0007029) | 2.18667850 |
| 118 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.18628579 |
| 119 | positive regulation of muscle hypertrophy (GO:0014742) | 2.18628579 |
| 120 | relaxation of smooth muscle (GO:0044557) | 2.18507133 |
| 121 | Golgi to plasma membrane protein transport (GO:0043001) | 2.18287204 |
| 122 | Sertoli cell development (GO:0060009) | 2.17914159 |
| 123 | regulation of dendritic spine development (GO:0060998) | 2.16983804 |
| 124 | auditory receptor cell differentiation (GO:0042491) | 2.16820536 |
| 125 | positive regulation of dendritic spine development (GO:0060999) | 2.16781102 |
| 126 | establishment of protein localization to Golgi (GO:0072600) | 2.16518092 |
| 127 | ribonucleoprotein complex disassembly (GO:0032988) | 2.15390944 |
| 128 | ER overload response (GO:0006983) | 2.15140429 |
| 129 | nuclear pore organization (GO:0006999) | 2.13601364 |
| 130 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.13362217 |
| 131 | establishment of mitochondrion localization (GO:0051654) | 2.13317747 |
| 132 | short-chain fatty acid metabolic process (GO:0046459) | 2.13317214 |
| 133 | omega-hydroxylase P450 pathway (GO:0097267) | 2.12504583 |
| 134 | positive regulation of glycogen metabolic process (GO:0070875) | 2.12252095 |
| 135 | synaptic vesicle endocytosis (GO:0048488) | 2.12103429 |
| 136 | retinal cone cell development (GO:0046549) | 2.11848952 |
| 137 | mechanosensory behavior (GO:0007638) | 2.11503049 |
| 138 | nucleus localization (GO:0051647) | 2.11470441 |
| 139 | inositol metabolic process (GO:0006020) | 2.11339371 |
| 140 | fatty acid homeostasis (GO:0055089) | 2.09855288 |
| 141 | negative regulation of sodium ion transport (GO:0010766) | 2.09826811 |
| 142 | valine metabolic process (GO:0006573) | 2.09772892 |
| 143 | neuronal action potential propagation (GO:0019227) | 2.08515842 |
| 144 | cellular sodium ion homeostasis (GO:0006883) | 2.08190983 |
| 145 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.06483117 |
| 146 | L-phenylalanine catabolic process (GO:0006559) | 2.06483117 |
| 147 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.05635033 |
| 148 | signal release (GO:0023061) | 2.05064283 |
| 149 | tricarboxylic acid metabolic process (GO:0072350) | 2.04806188 |
| 150 | type B pancreatic cell development (GO:0003323) | 2.03875362 |
| 151 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 2.02923404 |
| 152 | cellular zinc ion homeostasis (GO:0006882) | 2.02907161 |
| 153 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.02766160 |
| 154 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.02766160 |
| 155 | meiotic cell cycle (GO:0051321) | 2.01951314 |
| 156 | organelle transport along microtubule (GO:0072384) | 2.01947643 |
| 157 | long-term synaptic potentiation (GO:0060291) | 2.00918107 |
| 158 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 1.99535628 |
| 159 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 1.99070909 |
| 160 | Golgi to plasma membrane transport (GO:0006893) | 1.98952579 |
| 161 | C4-dicarboxylate transport (GO:0015740) | 1.98530412 |
| 162 | clathrin coat assembly (GO:0048268) | 1.97863781 |
| 163 | positive regulation of potassium ion transport (GO:0043268) | 1.97613584 |
| 164 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 1.97462333 |
| 165 | response to vitamin E (GO:0033197) | 1.97127793 |
| 166 | neuronal action potential (GO:0019228) | 1.96883559 |
| 167 | positive regulation of insulin secretion (GO:0032024) | 1.96747533 |
| 168 | regulation of timing of cell differentiation (GO:0048505) | 1.95728946 |
| 169 | central nervous system neuron axonogenesis (GO:0021955) | 1.95277339 |
| 170 | auditory receptor cell stereocilium organization (GO:0060088) | 1.94570981 |
| 171 | protein polyglutamylation (GO:0018095) | 1.94317790 |
| 172 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 1.93765584 |
| 173 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 1.93492646 |
| 174 | mitochondrion transport along microtubule (GO:0047497) | 1.93492646 |
| 175 | keratinocyte development (GO:0003334) | 1.92980584 |
| 176 | regulation of cell communication by electrical coupling (GO:0010649) | 1.91895596 |
| 177 | male sex determination (GO:0030238) | 1.91817807 |
| 178 | negative regulation of activin receptor signaling pathway (GO:0032926) | 1.90306334 |
| 179 | retinal metabolic process (GO:0042574) | 1.89851514 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.63023750 |
| 2 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.25640256 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.90110761 |
| 4 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.49166019 |
| 5 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.28014688 |
| 6 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.15011678 |
| 7 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.14471381 |
| 8 | FUS_26573619_Chip-Seq_HEK293_Human | 2.11189019 |
| 9 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.08215721 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.97646831 |
| 11 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.95327733 |
| 12 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.93269110 |
| 13 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.85362707 |
| 14 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.78928797 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 1.78598152 |
| 16 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.77678254 |
| 17 | VDR_22108803_ChIP-Seq_LS180_Human | 1.76483666 |
| 18 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.75354883 |
| 19 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.75045522 |
| 20 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.73554910 |
| 21 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.71603168 |
| 22 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.71228077 |
| 23 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.71186722 |
| 24 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.69850885 |
| 25 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.66937615 |
| 26 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.66820654 |
| 27 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.64618957 |
| 28 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.63257147 |
| 29 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.61861191 |
| 30 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.61205145 |
| 31 | EWS_26573619_Chip-Seq_HEK293_Human | 1.59361649 |
| 32 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.58942186 |
| 33 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.58824024 |
| 34 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.58824024 |
| 35 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.57343935 |
| 36 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.55097151 |
| 37 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.53988906 |
| 38 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.51830303 |
| 39 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.51499326 |
| 40 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.51431775 |
| 41 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.48683062 |
| 42 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.47096675 |
| 43 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.45847942 |
| 44 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.44290197 |
| 45 | P300_19829295_ChIP-Seq_ESCs_Human | 1.44166674 |
| 46 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.43812939 |
| 47 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.42830777 |
| 48 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.42494489 |
| 49 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.41885138 |
| 50 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.38874270 |
| 51 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.38301675 |
| 52 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.35723079 |
| 53 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.34544239 |
| 54 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.34503969 |
| 55 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.34442353 |
| 56 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.34041915 |
| 57 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.33911989 |
| 58 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.33749865 |
| 59 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.33258154 |
| 60 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.32720869 |
| 61 | TP53_16413492_ChIP-PET_HCT116_Human | 1.30905891 |
| 62 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.30769419 |
| 63 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.28902176 |
| 64 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.28894877 |
| 65 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.28840390 |
| 66 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.28780399 |
| 67 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.28080018 |
| 68 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.27752349 |
| 69 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.27027518 |
| 70 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.26905484 |
| 71 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.26612816 |
| 72 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.25371309 |
| 73 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.24837653 |
| 74 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.24134016 |
| 75 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.24124705 |
| 76 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.22915743 |
| 77 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.22564965 |
| 78 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20844438 |
| 79 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.20584218 |
| 80 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20179944 |
| 81 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.19517620 |
| 82 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.18593818 |
| 83 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.17691011 |
| 84 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.16399685 |
| 85 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.16399685 |
| 86 | JUN_21703547_ChIP-Seq_K562_Human | 1.16077472 |
| 87 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.15910490 |
| 88 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.15753296 |
| 89 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.14063861 |
| 90 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13728352 |
| 91 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.13728352 |
| 92 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.13485434 |
| 93 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13460657 |
| 94 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12849096 |
| 95 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.12747823 |
| 96 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.12529630 |
| 97 | AR_19668381_ChIP-Seq_PC3_Human | 1.11101036 |
| 98 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.10583877 |
| 99 | TCF4_23295773_ChIP-Seq_U87_Human | 1.10525434 |
| 100 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09491650 |
| 101 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.09400474 |
| 102 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.08714279 |
| 103 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.07787774 |
| 104 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.07488499 |
| 105 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.06828415 |
| 106 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.06483287 |
| 107 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.06444733 |
| 108 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.05678277 |
| 109 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.04842932 |
| 110 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.04661989 |
| 111 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.04525453 |
| 112 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.03078602 |
| 113 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.02998086 |
| 114 | RXR_22108803_ChIP-Seq_LS180_Human | 1.01698505 |
| 115 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.01497628 |
| 116 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.01189684 |
| 117 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.01128584 |
| 118 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.00907999 |
| 119 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.00903840 |
| 120 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.00670767 |
| 121 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.00223060 |
| 122 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.99884263 |
| 123 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.99612515 |
| 124 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.99481635 |
| 125 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.99284445 |
| 126 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.99110121 |
| 127 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.99103884 |
| 128 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.98919467 |
| 129 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.98724538 |
| 130 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.98350217 |
| 131 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.98120363 |
| 132 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.97054182 |
| 133 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.96779870 |
| 134 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96531106 |
| 135 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.95647283 |
| 136 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.95647283 |
| 137 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.95375988 |
| 138 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.94195253 |
| 139 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.93778421 |
| 140 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.93662757 |
| 141 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.93201602 |
| 142 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.92426160 |
| 143 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.92154371 |
| 144 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.91574545 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 3.92495899 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 3.22444541 |
| 3 | MP0009780_abnormal_chondrocyte_physiolo | 3.12851886 |
| 4 | MP0008057_abnormal_DNA_replication | 2.78444672 |
| 5 | MP0005645_abnormal_hypothalamus_physiol | 2.57224921 |
| 6 | MP0003635_abnormal_synaptic_transmissio | 2.48903843 |
| 7 | MP0003183_abnormal_peptide_metabolism | 2.41853834 |
| 8 | MP0008877_abnormal_DNA_methylation | 2.35138361 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 2.35010725 |
| 10 | MP0005365_abnormal_bile_salt | 2.28623836 |
| 11 | MP0002063_abnormal_learning/memory/cond | 2.23367270 |
| 12 | MP0002909_abnormal_adrenal_gland | 2.21862107 |
| 13 | MP0005646_abnormal_pituitary_gland | 2.08877846 |
| 14 | MP0002876_abnormal_thyroid_physiology | 2.08441693 |
| 15 | MP0000566_synostosis | 2.03348428 |
| 16 | MP0003252_abnormal_bile_duct | 1.97561744 |
| 17 | MP0003300_gastrointestinal_ulcer | 1.95711374 |
| 18 | MP0010234_abnormal_vibrissa_follicle | 1.92580723 |
| 19 | MP0009745_abnormal_behavioral_response | 1.91688903 |
| 20 | MP0000427_abnormal_hair_cycle | 1.90138068 |
| 21 | MP0004270_analgesia | 1.87236029 |
| 22 | MP0000013_abnormal_adipose_tissue | 1.86635489 |
| 23 | MP0005360_urolithiasis | 1.83696045 |
| 24 | MP0004130_abnormal_muscle_cell | 1.82904762 |
| 25 | MP0004885_abnormal_endolymph | 1.81674406 |
| 26 | MP0003122_maternal_imprinting | 1.80567424 |
| 27 | MP0002064_seizures | 1.68695822 |
| 28 | MP0003724_increased_susceptibility_to | 1.65776958 |
| 29 | MP0002009_preneoplasia | 1.62035579 |
| 30 | MP0002572_abnormal_emotion/affect_behav | 1.61978523 |
| 31 | MP0010386_abnormal_urinary_bladder | 1.60109334 |
| 32 | MP0002557_abnormal_social/conspecific_i | 1.59196559 |
| 33 | MP0005535_abnormal_body_temperature | 1.52382384 |
| 34 | MP0001984_abnormal_olfaction | 1.50126879 |
| 35 | MP0001944_abnormal_pancreas_morphology | 1.49614919 |
| 36 | MP0010329_abnormal_lipoprotein_level | 1.48355983 |
| 37 | MP0006054_spinal_hemorrhage | 1.47400833 |
| 38 | MP0003787_abnormal_imprinting | 1.46476594 |
| 39 | MP0002166_altered_tumor_susceptibility | 1.43515555 |
| 40 | MP0003172_abnormal_lysosome_physiology | 1.43438246 |
| 41 | MP0006276_abnormal_autonomic_nervous | 1.42339326 |
| 42 | MP0003633_abnormal_nervous_system | 1.41028029 |
| 43 | MP0005423_abnormal_somatic_nervous | 1.40944768 |
| 44 | MP0001501_abnormal_sleep_pattern | 1.39997078 |
| 45 | MP0001486_abnormal_startle_reflex | 1.37362479 |
| 46 | MP0008569_lethality_at_weaning | 1.34455115 |
| 47 | MP0002693_abnormal_pancreas_physiology | 1.34330228 |
| 48 | MP0002078_abnormal_glucose_homeostasis | 1.31529870 |
| 49 | MP0003283_abnormal_digestive_organ | 1.30691740 |
| 50 | MP0001968_abnormal_touch/_nociception | 1.28473728 |
| 51 | MP0002272_abnormal_nervous_system | 1.26897323 |
| 52 | MP0002928_abnormal_bile_duct | 1.26117817 |
| 53 | MP0004147_increased_porphyrin_level | 1.23695723 |
| 54 | MP0003868_abnormal_feces_composition | 1.22385942 |
| 55 | MP0002877_abnormal_melanocyte_morpholog | 1.21673153 |
| 56 | MP0010678_abnormal_skin_adnexa | 1.21411647 |
| 57 | MP0004043_abnormal_pH_regulation | 1.21254442 |
| 58 | MP0004811_abnormal_neuron_physiology | 1.20066269 |
| 59 | MP0003880_abnormal_central_pattern | 1.19083008 |
| 60 | MP0003950_abnormal_plasma_membrane | 1.18927986 |
| 61 | MP0005551_abnormal_eye_electrophysiolog | 1.18125709 |
| 62 | MP0005408_hypopigmentation | 1.17939625 |
| 63 | MP0001879_abnormal_lymphatic_vessel | 1.16900098 |
| 64 | MP0002067_abnormal_sensory_capabilities | 1.14996546 |
| 65 | MP0005220_abnormal_exocrine_pancreas | 1.14858222 |
| 66 | MP0002638_abnormal_pupillary_reflex | 1.14791826 |
| 67 | MP0008875_abnormal_xenobiotic_pharmacok | 1.14332190 |
| 68 | MP0000383_abnormal_hair_follicle | 1.13944494 |
| 69 | MP0005085_abnormal_gallbladder_physiolo | 1.11987321 |
| 70 | MP0002734_abnormal_mechanical_nocicepti | 1.11454806 |
| 71 | MP0005174_abnormal_tail_pigmentation | 1.10090097 |
| 72 | MP0002160_abnormal_reproductive_system | 1.08014737 |
| 73 | MP0002837_dystrophic_cardiac_calcinosis | 1.06747265 |
| 74 | MP0010352_gastrointestinal_tract_polyps | 1.06393424 |
| 75 | MP0002822_catalepsy | 1.06279457 |
| 76 | MP0005379_endocrine/exocrine_gland_phen | 1.05200645 |
| 77 | MP0005386_behavior/neurological_phenoty | 1.05095820 |
| 78 | MP0004924_abnormal_behavior | 1.05095820 |
| 79 | MP0008961_abnormal_basal_metabolism | 1.03396312 |
| 80 | MP0003943_abnormal_hepatobiliary_system | 1.01470572 |
| 81 | MP0002090_abnormal_vision | 0.99650870 |
| 82 | MP0001177_atelectasis | 0.98602480 |
| 83 | MP0000462_abnormal_digestive_system | 0.97632383 |
| 84 | MP0003195_calcinosis | 0.96525219 |
| 85 | MP0000647_abnormal_sebaceous_gland | 0.96491367 |
| 86 | MP0005167_abnormal_blood-brain_barrier | 0.96068448 |
| 87 | MP0001502_abnormal_circadian_rhythm | 0.94827272 |
| 88 | MP0001666_abnormal_nutrient_absorption | 0.94145186 |
| 89 | MP0003385_abnormal_body_wall | 0.93065474 |
| 90 | MP0001299_abnormal_eye_distance/ | 0.92207772 |
| 91 | MP0002118_abnormal_lipid_homeostasis | 0.92097978 |
| 92 | MP0004134_abnormal_chest_morphology | 0.91157478 |
| 93 | MP0002733_abnormal_thermal_nociception | 0.90469893 |
| 94 | MP0002751_abnormal_autonomic_nervous | 0.89792360 |
| 95 | MP0000778_abnormal_nervous_system | 0.89345116 |
| 96 | MP0009046_muscle_twitch | 0.89330081 |
| 97 | MP0005248_abnormal_Harderian_gland | 0.88772921 |
| 98 | MP0005448_abnormal_energy_balance | 0.88760604 |
| 99 | MP0002971_abnormal_brown_adipose | 0.88302066 |
| 100 | MP0005084_abnormal_gallbladder_morpholo | 0.87812513 |
| 101 | MP0003632_abnormal_nervous_system | 0.87691558 |
| 102 | MP0005670_abnormal_white_adipose | 0.87486140 |
| 103 | MP0002184_abnormal_innervation | 0.87005120 |
| 104 | MP0008789_abnormal_olfactory_epithelium | 0.84768917 |
| 105 | MP0002098_abnormal_vibrissa_morphology | 0.84215538 |
| 106 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.84056197 |
| 107 | MP0000003_abnormal_adipose_tissue | 0.83404586 |
| 108 | MP0009697_abnormal_copulation | 0.83141935 |
| 109 | MP0005409_darkened_coat_color | 0.82706046 |
| 110 | MP0004215_abnormal_myocardial_fiber | 0.82141023 |
| 111 | MP0002735_abnormal_chemical_nociception | 0.81775782 |
| 112 | MP0001270_distended_abdomen | 0.80663128 |
| 113 | MP0003953_abnormal_hormone_level | 0.80531936 |
| 114 | MP0000631_abnormal_neuroendocrine_gland | 0.79243911 |
| 115 | MP0005334_abnormal_fat_pad | 0.78859673 |
| 116 | MP0003631_nervous_system_phenotype | 0.78748878 |
| 117 | MP0003690_abnormal_glial_cell | 0.77385534 |
| 118 | MP0000955_abnormal_spinal_cord | 0.76757753 |
| 119 | MP0003890_abnormal_embryonic-extraembry | 0.76561963 |
| 120 | MP0000230_abnormal_systemic_arterial | 0.76524484 |
| 121 | MP0002069_abnormal_eating/drinking_beha | 0.76126819 |
| 122 | MP0002234_abnormal_pharynx_morphology | 0.75477369 |
| 123 | MP0003123_paternal_imprinting | 0.75419287 |
| 124 | MP0001929_abnormal_gametogenesis | 0.75238868 |
| 125 | MP0002006_tumorigenesis | 0.75176062 |
| 126 | MP0000639_abnormal_adrenal_gland | 0.74658478 |
| 127 | MP0005332_abnormal_amino_acid | 0.74617437 |
| 128 | MP0003121_genomic_imprinting | 0.73826711 |
| 129 | MP0005187_abnormal_penis_morphology | 0.73749727 |
| 130 | MP0002882_abnormal_neuron_morphology | 0.73596339 |
| 131 | MP0009115_abnormal_fat_cell | 0.73198759 |
| 132 | MP0003075_altered_response_to | 0.72542043 |
| 133 | MP0003656_abnormal_erythrocyte_physiolo | 0.72023909 |
| 134 | MP0004084_abnormal_cardiac_muscle | 0.71530506 |
| 135 | MP0001970_abnormal_pain_threshold | 0.71061948 |
| 136 | MP0002210_abnormal_sex_determination | 0.71045593 |
| 137 | MP0005394_taste/olfaction_phenotype | 0.70382961 |
| 138 | MP0005499_abnormal_olfactory_system | 0.70382961 |
| 139 | MP0004085_abnormal_heartbeat | 0.63784444 |
| 140 | MP0003959_abnormal_lean_body | 0.63679775 |
| 141 | MP0003942_abnormal_urinary_system | 0.63640721 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic seizures (HP:0002173) | 3.88309769 |
| 2 | Visual hallucinations (HP:0002367) | 3.78927057 |
| 3 | Agitation (HP:0000713) | 3.70903806 |
| 4 | Focal motor seizures (HP:0011153) | 3.46914931 |
| 5 | Papilledema (HP:0001085) | 3.42744242 |
| 6 | Papillary thyroid carcinoma (HP:0002895) | 3.37945333 |
| 7 | Ketoacidosis (HP:0001993) | 3.36914971 |
| 8 | Volvulus (HP:0002580) | 3.20399134 |
| 9 | Hypoglycemic coma (HP:0001325) | 3.18457145 |
| 10 | Septate vagina (HP:0001153) | 3.13582498 |
| 11 | Symptomatic seizures (HP:0011145) | 3.07022742 |
| 12 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.93171794 |
| 13 | Hyperventilation (HP:0002883) | 2.90833732 |
| 14 | Truncal ataxia (HP:0002078) | 2.87599937 |
| 15 | Genetic anticipation (HP:0003743) | 2.73700493 |
| 16 | Methylmalonic aciduria (HP:0012120) | 2.71711193 |
| 17 | Ketosis (HP:0001946) | 2.70485511 |
| 18 | Progressive cerebellar ataxia (HP:0002073) | 2.66982487 |
| 19 | Oligomenorrhea (HP:0000876) | 2.62507495 |
| 20 | Focal seizures (HP:0007359) | 2.62428495 |
| 21 | Thyroid carcinoma (HP:0002890) | 2.61522442 |
| 22 | Macroorchidism (HP:0000053) | 2.61382894 |
| 23 | Action tremor (HP:0002345) | 2.60390392 |
| 24 | Generalized hypopigmentation of hair (HP:0011358) | 2.55454405 |
| 25 | Fair hair (HP:0002286) | 2.50373988 |
| 26 | Depression (HP:0000716) | 2.49202963 |
| 27 | Poor eye contact (HP:0000817) | 2.46561341 |
| 28 | Abnormality of the common coagulation pathway (HP:0010990) | 2.42789118 |
| 29 | Insidious onset (HP:0003587) | 2.41745986 |
| 30 | Termporal pattern (HP:0011008) | 2.41745986 |
| 31 | Abnormality of the corticospinal tract (HP:0002492) | 2.39876915 |
| 32 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.39068497 |
| 33 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.39068497 |
| 34 | Cubitus valgus (HP:0002967) | 2.36823087 |
| 35 | Short chin (HP:0000331) | 2.32794544 |
| 36 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.32471035 |
| 37 | Abnormal social behavior (HP:0012433) | 2.29027173 |
| 38 | Impaired social interactions (HP:0000735) | 2.29027173 |
| 39 | Abnormal eating behavior (HP:0100738) | 2.27179598 |
| 40 | Febrile seizures (HP:0002373) | 2.24145343 |
| 41 | Curly hair (HP:0002212) | 2.23530824 |
| 42 | Generalized tonic-clonic seizures (HP:0002069) | 2.23305272 |
| 43 | Metaphyseal dysplasia (HP:0100255) | 2.22546040 |
| 44 | Polyphagia (HP:0002591) | 2.22301951 |
| 45 | Renal cortical cysts (HP:0000803) | 2.22229272 |
| 46 | Anxiety (HP:0000739) | 2.21857692 |
| 47 | Narrow nasal bridge (HP:0000446) | 2.19469790 |
| 48 | Blue irides (HP:0000635) | 2.17561750 |
| 49 | Limb hypertonia (HP:0002509) | 2.13126216 |
| 50 | Hamartoma of the eye (HP:0010568) | 2.11980287 |
| 51 | Abnormality of the intrinsic pathway (HP:0010989) | 2.09458333 |
| 52 | Increased serum pyruvate (HP:0003542) | 2.09172369 |
| 53 | Myokymia (HP:0002411) | 2.08817762 |
| 54 | Hemiplegia (HP:0002301) | 2.07140071 |
| 55 | Amyotrophic lateral sclerosis (HP:0007354) | 2.02430260 |
| 56 | Proximal tubulopathy (HP:0000114) | 2.01583067 |
| 57 | Tetraplegia (HP:0002445) | 2.01212904 |
| 58 | EEG with generalized epileptiform discharges (HP:0011198) | 1.99897356 |
| 59 | Facial hemangioma (HP:0000329) | 1.99863940 |
| 60 | Overlapping toe (HP:0001845) | 1.99718646 |
| 61 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.99094210 |
| 62 | Epileptiform EEG discharges (HP:0011182) | 1.98307596 |
| 63 | Pheochromocytoma (HP:0002666) | 1.97390347 |
| 64 | Drooling (HP:0002307) | 1.97210513 |
| 65 | Excessive salivation (HP:0003781) | 1.97210513 |
| 66 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.96853453 |
| 67 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.96853453 |
| 68 | Neuroendocrine neoplasm (HP:0100634) | 1.95833968 |
| 69 | Deep venous thrombosis (HP:0002625) | 1.95125936 |
| 70 | Focal dystonia (HP:0004373) | 1.94314122 |
| 71 | Spinal canal stenosis (HP:0003416) | 1.94010252 |
| 72 | Abnormality of the renal cortex (HP:0011035) | 1.93968134 |
| 73 | Hypsarrhythmia (HP:0002521) | 1.93940095 |
| 74 | Complement deficiency (HP:0004431) | 1.92904163 |
| 75 | Growth hormone excess (HP:0000845) | 1.92903318 |
| 76 | Intention tremor (HP:0002080) | 1.91992674 |
| 77 | Absence seizures (HP:0002121) | 1.91981860 |
| 78 | Horizontal nystagmus (HP:0000666) | 1.91336138 |
| 79 | Increased CSF protein (HP:0002922) | 1.91132250 |
| 80 | Scanning speech (HP:0002168) | 1.90841406 |
| 81 | Decreased circulating renin level (HP:0003351) | 1.89176027 |
| 82 | Truncal obesity (HP:0001956) | 1.88637278 |
| 83 | Torticollis (HP:0000473) | 1.87936943 |
| 84 | Medial flaring of the eyebrow (HP:0010747) | 1.87631985 |
| 85 | Hypoalphalipoproteinemia (HP:0003233) | 1.87041666 |
| 86 | Striae distensae (HP:0001065) | 1.86792427 |
| 87 | Epileptic encephalopathy (HP:0200134) | 1.85835957 |
| 88 | Chronic hepatic failure (HP:0100626) | 1.85664578 |
| 89 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.84980579 |
| 90 | Neoplasm of the thyroid gland (HP:0100031) | 1.84962297 |
| 91 | Hypoventilation (HP:0002791) | 1.84192921 |
| 92 | Furrowed tongue (HP:0000221) | 1.83357309 |
| 93 | Gait imbalance (HP:0002141) | 1.83290942 |
| 94 | Menstrual irregularities (HP:0000858) | 1.82940189 |
| 95 | Craniofacial dystonia (HP:0012179) | 1.82773181 |
| 96 | Exotropia (HP:0000577) | 1.81747285 |
| 97 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.81724734 |
| 98 | Mitral stenosis (HP:0001718) | 1.80579850 |
| 99 | Menorrhagia (HP:0000132) | 1.80051630 |
| 100 | Short 1st metacarpal (HP:0010034) | 1.79636631 |
| 101 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.79636631 |
| 102 | Fatigue (HP:0012378) | 1.79329292 |
| 103 | Conjunctival hamartoma (HP:0100780) | 1.79216983 |
| 104 | Astrocytoma (HP:0009592) | 1.77928929 |
| 105 | Abnormality of the astrocytes (HP:0100707) | 1.77928929 |
| 106 | Late onset (HP:0003584) | 1.77198141 |
| 107 | Gaze-evoked nystagmus (HP:0000640) | 1.77125575 |
| 108 | Abnormality of glycolysis (HP:0004366) | 1.75689525 |
| 109 | Dysdiadochokinesis (HP:0002075) | 1.75385328 |
| 110 | Psychosis (HP:0000709) | 1.75372732 |
| 111 | Heterotopia (HP:0002282) | 1.75330851 |
| 112 | Exocrine pancreatic insufficiency (HP:0001738) | 1.74260204 |
| 113 | Impaired smooth pursuit (HP:0007772) | 1.74071147 |
| 114 | Failure to thrive in infancy (HP:0001531) | 1.73252551 |
| 115 | Glioma (HP:0009733) | 1.72821840 |
| 116 | Hypoplasia of the thymus (HP:0000778) | 1.72131161 |
| 117 | Conjugated hyperbilirubinemia (HP:0002908) | 1.71894533 |
| 118 | Increased circulating renin level (HP:0000848) | 1.71794511 |
| 119 | Epidermoid cyst (HP:0200040) | 1.71455167 |
| 120 | Congenital primary aphakia (HP:0007707) | 1.71424459 |
| 121 | Open mouth (HP:0000194) | 1.70460136 |
| 122 | Thickened nuchal skin fold (HP:0000474) | 1.70297478 |
| 123 | Hypothermia (HP:0002045) | 1.67753736 |
| 124 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.67694586 |
| 125 | Atonic seizures (HP:0010819) | 1.67502054 |
| 126 | Abnormal hair whorl (HP:0010721) | 1.67153576 |
| 127 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.67120108 |
| 128 | Joint hemorrhage (HP:0005261) | 1.66645452 |
| 129 | Pancreatic cysts (HP:0001737) | 1.66185371 |
| 130 | Thick eyebrow (HP:0000574) | 1.66132541 |
| 131 | Dialeptic seizures (HP:0011146) | 1.64424455 |
| 132 | Prolonged bleeding time (HP:0003010) | 1.63747638 |
| 133 | Intestinal atresia (HP:0011100) | 1.63467762 |
| 134 | Sandal gap (HP:0001852) | 1.63354545 |
| 135 | Intrahepatic cholestasis (HP:0001406) | 1.63342076 |
| 136 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.63013530 |
| 137 | Microglossia (HP:0000171) | 1.61893640 |
| 138 | Prolonged partial thromboplastin time (HP:0003645) | 1.61800367 |
| 139 | Hamartoma (HP:0010566) | 1.61558272 |
| 140 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.61555656 |
| 141 | Mucopolysacchariduria (HP:0008155) | 1.61555656 |
| 142 | Protruding tongue (HP:0010808) | 1.61130626 |
| 143 | Progressive inability to walk (HP:0002505) | 1.61104836 |
| 144 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.60997046 |
| 145 | Widely spaced teeth (HP:0000687) | 1.60987840 |
| 146 | Hyperglycemia (HP:0003074) | 1.60888575 |
| 147 | Osteomalacia (HP:0002749) | 1.60811442 |
| 148 | Double outlet right ventricle (HP:0001719) | 1.60548834 |
| 149 | Congenital malformation of the right heart (HP:0011723) | 1.60548834 |
| 150 | Absent speech (HP:0001344) | 1.60261389 |
| 151 | Short tibia (HP:0005736) | 1.59986937 |
| 152 | Cystic hygroma (HP:0000476) | 1.59915234 |
| 153 | Urinary urgency (HP:0000012) | 1.59553690 |
| 154 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.59465127 |
| 155 | Hyperlipoproteinemia (HP:0010980) | 1.58877989 |
| 156 | Nephrogenic diabetes insipidus (HP:0009806) | 1.58838209 |
| 157 | Pancreatic fibrosis (HP:0100732) | 1.58492759 |
| 158 | Status epilepticus (HP:0002133) | 1.58410863 |
| 159 | Gait ataxia (HP:0002066) | 1.58382525 |
| 160 | Genital tract atresia (HP:0001827) | 1.55967325 |
| 161 | Hypolipoproteinemia (HP:0010981) | 1.55817668 |
| 162 | Abnormal biliary tract morphology (HP:0012440) | 1.54091225 |
| 163 | Deep philtrum (HP:0002002) | 1.53675680 |
| 164 | Meningioma (HP:0002858) | 1.53502624 |
| 165 | Intellectual disability, progressive (HP:0006887) | 1.53443479 |
| 166 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.53219124 |
| 167 | Broad-based gait (HP:0002136) | 1.52819300 |
| 168 | Sparse lateral eyebrow (HP:0005338) | 1.52700001 |
| 169 | Inability to walk (HP:0002540) | 1.52096778 |
| 170 | Gonadotropin excess (HP:0000837) | 1.51927151 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 3.55641402 |
| 2 | SIK3 | 2.61741002 |
| 3 | CCNB1 | 2.48905108 |
| 4 | MAP3K12 | 2.43034256 |
| 5 | PNCK | 2.40439520 |
| 6 | ERBB3 | 2.33455470 |
| 7 | NTRK3 | 2.27283339 |
| 8 | MAP2K4 | 2.08709561 |
| 9 | MAP2K7 | 2.00356706 |
| 10 | CAMKK2 | 1.90457983 |
| 11 | MINK1 | 1.85723129 |
| 12 | SGK2 | 1.74685739 |
| 13 | FER | 1.72009606 |
| 14 | MAP3K4 | 1.71404237 |
| 15 | WNK3 | 1.69530938 |
| 16 | TAOK3 | 1.65377293 |
| 17 | SIK2 | 1.60655000 |
| 18 | EIF2AK3 | 1.57431163 |
| 19 | FGFR3 | 1.51651238 |
| 20 | MAP3K6 | 1.50486741 |
| 21 | CAMK1G | 1.47586274 |
| 22 | CDK8 | 1.43477950 |
| 23 | PRKCH | 1.40810227 |
| 24 | CSNK1G1 | 1.38503128 |
| 25 | CSNK1A1L | 1.38258675 |
| 26 | SIK1 | 1.35556298 |
| 27 | CSNK1G3 | 1.34745604 |
| 28 | JAK1 | 1.34114286 |
| 29 | SGK3 | 1.29536003 |
| 30 | STK3 | 1.27418388 |
| 31 | SGK494 | 1.25912425 |
| 32 | SGK223 | 1.25912425 |
| 33 | FRK | 1.24324882 |
| 34 | ERN1 | 1.24030504 |
| 35 | PIK3CA | 1.23061574 |
| 36 | PRKD3 | 1.21584274 |
| 37 | NEK6 | 1.21505521 |
| 38 | PAK3 | 1.19518141 |
| 39 | CAMKK1 | 1.18546373 |
| 40 | STK38L | 1.17412271 |
| 41 | RET | 1.16308046 |
| 42 | ZAP70 | 1.16292293 |
| 43 | NTRK2 | 1.16233428 |
| 44 | PKN1 | 1.15931413 |
| 45 | CLK1 | 1.15592546 |
| 46 | RIPK4 | 1.15472855 |
| 47 | FGFR2 | 1.11773351 |
| 48 | DAPK2 | 1.09649940 |
| 49 | ACVR1B | 1.08343190 |
| 50 | DAPK1 | 1.07836368 |
| 51 | TRIB3 | 1.07560715 |
| 52 | HIPK2 | 1.03678765 |
| 53 | CASK | 1.03435123 |
| 54 | MAPK13 | 1.02916224 |
| 55 | MAP4K2 | 1.01784625 |
| 56 | MARK1 | 1.01501631 |
| 57 | FES | 1.00745408 |
| 58 | SCYL2 | 1.00223249 |
| 59 | MAP3K9 | 0.99183231 |
| 60 | IRAK2 | 0.98474799 |
| 61 | KSR1 | 0.98156500 |
| 62 | TEC | 0.97216526 |
| 63 | EIF2AK1 | 0.97129669 |
| 64 | LATS1 | 0.97001382 |
| 65 | MET | 0.96914474 |
| 66 | EPHA4 | 0.94028829 |
| 67 | WNK1 | 0.92562865 |
| 68 | SYK | 0.91968942 |
| 69 | FLT3 | 0.91523725 |
| 70 | LMTK2 | 0.91499540 |
| 71 | RIPK1 | 0.91149666 |
| 72 | STK39 | 0.88136083 |
| 73 | FGFR4 | 0.87273320 |
| 74 | CDK5 | 0.85458403 |
| 75 | TRIM28 | 0.85197325 |
| 76 | MAPK15 | 0.84933992 |
| 77 | NEK9 | 0.84875513 |
| 78 | EPHA3 | 0.83343196 |
| 79 | BRSK2 | 0.82983863 |
| 80 | PINK1 | 0.81617158 |
| 81 | TXK | 0.81302934 |
| 82 | PIK3CG | 0.81024114 |
| 83 | TRPM7 | 0.80547636 |
| 84 | CAMK2B | 0.77750684 |
| 85 | PHKG1 | 0.77630858 |
| 86 | PHKG2 | 0.77630858 |
| 87 | PDGFRA | 0.77007769 |
| 88 | TNK2 | 0.75226447 |
| 89 | BMPR2 | 0.74229942 |
| 90 | RPS6KB1 | 0.73567260 |
| 91 | PDK1 | 0.72910952 |
| 92 | JAK2 | 0.72780089 |
| 93 | PRKCE | 0.72657417 |
| 94 | PASK | 0.71270318 |
| 95 | IRAK1 | 0.70979724 |
| 96 | PRKCG | 0.70550527 |
| 97 | KIT | 0.69724526 |
| 98 | TGFBR2 | 0.69549451 |
| 99 | CAMK2D | 0.69214183 |
| 100 | NTRK1 | 0.67278079 |
| 101 | CSNK1E | 0.66906206 |
| 102 | CAMK1D | 0.66637534 |
| 103 | CSNK1G2 | 0.66283608 |
| 104 | BCR | 0.65617457 |
| 105 | ITK | 0.63495668 |
| 106 | KSR2 | 0.63049952 |
| 107 | PKN2 | 0.62018111 |
| 108 | RPS6KA2 | 0.60878740 |
| 109 | SGK1 | 0.60486715 |
| 110 | TNIK | 0.59875572 |
| 111 | RAF1 | 0.58483549 |
| 112 | PRKAA1 | 0.57981650 |
| 113 | CAMK1 | 0.57002023 |
| 114 | PDPK1 | 0.56007304 |
| 115 | PLK2 | 0.55580362 |
| 116 | YES1 | 0.55136210 |
| 117 | FYN | 0.54191910 |
| 118 | PTK2 | 0.54115983 |
| 119 | TGFBR1 | 0.53377735 |
| 120 | CSNK1D | 0.53359816 |
| 121 | CAMK2A | 0.53063146 |
| 122 | DMPK | 0.52751645 |
| 123 | ATM | 0.50869625 |
| 124 | PRKCQ | 0.50427270 |
| 125 | BRD4 | 0.49927952 |
| 126 | CAMK2G | 0.49257926 |
| 127 | PRKCZ | 0.49177012 |
| 128 | IGF1R | 0.49094795 |
| 129 | DYRK1B | 0.48274235 |
| 130 | MAP3K2 | 0.48021240 |
| 131 | BMPR1B | 0.47416820 |
| 132 | BCKDK | 0.47246073 |
| 133 | JAK3 | 0.47143226 |
| 134 | MST1R | 0.46208179 |
| 135 | RPS6KA3 | 0.45127550 |
| 136 | BTK | 0.44765300 |
| 137 | UHMK1 | 0.43311347 |
| 138 | NEK1 | 0.43173883 |
| 139 | DYRK1A | 0.43052448 |
| 140 | HCK | 0.42632738 |
| 141 | ERBB2 | 0.42576683 |
| 142 | PRKACB | 0.42438882 |
| 143 | TIE1 | 0.42423487 |
| 144 | MAP3K5 | 0.42122141 |
| 145 | MAPK10 | 0.41417748 |
| 146 | MAP2K1 | 0.41115920 |
| 147 | AKT3 | 0.41093167 |
| 148 | ICK | 0.40339869 |
| 149 | CAMK4 | 0.40297032 |
| 150 | PRKCI | 0.39548732 |
| 151 | EIF2AK2 | 0.38649989 |
| 152 | MAPK14 | 0.36814702 |
| 153 | PAK2 | 0.36715566 |
| 154 | DYRK3 | 0.36601594 |
| 155 | * CDK1 | 0.35849740 |
| 156 | * GSK3B | 0.35035942 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.64977777 |
| 2 | Insulin secretion_Homo sapiens_hsa04911 | 1.98719653 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 1.91609849 |
| 4 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.87799566 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 1.83185235 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 1.80992312 |
| 7 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.73535426 |
| 8 | Nicotine addiction_Homo sapiens_hsa05033 | 1.71662553 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 1.71525962 |
| 10 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.64827030 |
| 11 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.64007583 |
| 12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.59872895 |
| 13 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.55179040 |
| 14 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.52061490 |
| 15 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.51833445 |
| 16 | Long-term potentiation_Homo sapiens_hsa04720 | 1.46741578 |
| 17 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.45952883 |
| 18 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.45110053 |
| 19 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.42697105 |
| 20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.40258184 |
| 21 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.39426418 |
| 22 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.35285499 |
| 23 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.34290839 |
| 24 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.32318583 |
| 25 | Basal transcription factors_Homo sapiens_hsa03022 | 1.31439560 |
| 26 | Taste transduction_Homo sapiens_hsa04742 | 1.30528257 |
| 27 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.29999650 |
| 28 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.28962095 |
| 29 | Cocaine addiction_Homo sapiens_hsa05030 | 1.27308841 |
| 30 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.27080852 |
| 31 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.25694746 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.22306842 |
| 33 | Renin secretion_Homo sapiens_hsa04924 | 1.20588469 |
| 34 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.17707468 |
| 35 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.12957885 |
| 36 | Retinol metabolism_Homo sapiens_hsa00830 | 1.11077706 |
| 37 | Salivary secretion_Homo sapiens_hsa04970 | 1.10967978 |
| 38 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.10362140 |
| 39 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.08053160 |
| 40 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.07145704 |
| 41 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.03929107 |
| 42 | Insulin resistance_Homo sapiens_hsa04931 | 1.01383271 |
| 43 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.00499112 |
| 44 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.98668134 |
| 45 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.95747063 |
| 46 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.95700289 |
| 47 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.94980164 |
| 48 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.90021825 |
| 49 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.89927516 |
| 50 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.89637110 |
| 51 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.87632463 |
| 52 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.86598943 |
| 53 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.86560191 |
| 54 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.85770970 |
| 55 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.84922540 |
| 56 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.84861837 |
| 57 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.84228192 |
| 58 | Bile secretion_Homo sapiens_hsa04976 | 0.84205498 |
| 59 | Glioma_Homo sapiens_hsa05214 | 0.83387889 |
| 60 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.82619677 |
| 61 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.81925854 |
| 62 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.81139813 |
| 63 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.80262159 |
| 64 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.79862525 |
| 65 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.78561910 |
| 66 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.78265470 |
| 67 | ABC transporters_Homo sapiens_hsa02010 | 0.78252940 |
| 68 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.77333428 |
| 69 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.75297952 |
| 70 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.74933504 |
| 71 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.74315907 |
| 72 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.71324274 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.70833299 |
| 74 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.69667066 |
| 75 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.69263761 |
| 76 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.68981382 |
| 77 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.68967860 |
| 78 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.68860445 |
| 79 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68855991 |
| 80 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.67928508 |
| 81 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.67042426 |
| 82 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.66830768 |
| 83 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.66296675 |
| 84 | Circadian rhythm_Homo sapiens_hsa04710 | 0.66251758 |
| 85 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.65311924 |
| 86 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.64885202 |
| 87 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.64489486 |
| 88 | Peroxisome_Homo sapiens_hsa04146 | 0.63904414 |
| 89 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.63445900 |
| 90 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.63406807 |
| 91 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.63290158 |
| 92 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.62778783 |
| 93 | Protein export_Homo sapiens_hsa03060 | 0.62538476 |
| 94 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.62137291 |
| 95 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.61843628 |
| 96 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.61681147 |
| 97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60828690 |
| 98 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.60794912 |
| 99 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.60421944 |
| 100 | Melanoma_Homo sapiens_hsa05218 | 0.60342800 |
| 101 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.59292117 |
| 102 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.59243954 |
| 103 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.59110600 |
| 104 | Mineral absorption_Homo sapiens_hsa04978 | 0.59009113 |
| 105 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.58826200 |
| 106 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.58605620 |
| 107 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58306726 |
| 108 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.57794113 |
| 109 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.57168258 |
| 110 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.56173103 |
| 111 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.54305488 |
| 112 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53734643 |
| 113 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.53359665 |
| 114 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.53280602 |
| 115 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.52511506 |
| 116 | Carbon metabolism_Homo sapiens_hsa01200 | 0.52428169 |
| 117 | Long-term depression_Homo sapiens_hsa04730 | 0.52297105 |
| 118 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.51515498 |
| 119 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.51418783 |
| 120 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.50847787 |
| 121 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.50488551 |
| 122 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.50353157 |
| 123 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.49571708 |
| 124 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.49032480 |
| 125 | Lysine degradation_Homo sapiens_hsa00310 | 0.48951979 |
| 126 | Platelet activation_Homo sapiens_hsa04611 | 0.48950055 |
| 127 | Melanogenesis_Homo sapiens_hsa04916 | 0.47456881 |
| 128 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.46671779 |
| 129 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45938760 |
| 130 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.45840757 |
| 131 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.45594754 |
| 132 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.44760721 |
| 133 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.40615667 |
| 134 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.39930448 |
| 135 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.39743744 |

